Who We Are
Who We Are
We build, test, and deliver new therapies to cure congenital heart defects, allowing families to live full, enriching lives.
Learn More
Our Story Our People Partnerships News/Blog
Our Work
Our Work
HeartWorks builds, tests, and delivers new therapies to cure congenital heart defects giving these families the opportunity to live full, enriching lives.
Learn More
We Build Hearts Lab Tours Stories The Co-op at HeartWorks
For Families
For Families
Families are the heart of HeartWorks. We work for the 1 in 100 impacted by congenital heart defects.
Learn More
Lab Tours One Heart by HeartWorks Family Team Pages The Co-op at HeartWorks
Get Involved
Get Involved
HeartWorks relies on our community to help fund the research and clinical trials that hope to find cures for congenital heart defects (CHD). Discover ways that you can help.
Learn More
Donate Donors Job Openings Events Shop Contact Us
Clinical Trials
Clinical Trials
HeartWorks is leading the world’s largest effort to develop new treatment options for CHD patients.
Learn More
Current Trials Clinical Trial Results Lab Tours
The Co-op
Donate

News & Blog

HeartWorks + Ashley Home Stores

Ashley is proud to partner with HeartWorks through the support of Ashley’s President and CEO, Todd Wanek and his wife Karen. Their philanthropic contributions have helped accelerate the expansion of the HeartWorks network and progress towards a cure for Congenital Heart Disease (CHD).

Share the Post:

Related Posts

Microscope image of fibroblast production

From Skin Cells to Heart Cells: How HeartWorks Is Building Regenerative Therapies

HeartWorks was created to accelerate therapies for congenital heart disease by bringing research, manufacturing, and clinical care together under one mission.At HeartWorks, our regenerative medicine platform begins with something remarkably simple: a small skin biopsy.

Those cells are reprogrammed into stem cells, expanded in our manufacturing facility, and then transformed into bioengineered heart muscle cells – all using the patient’s own cells. The goal? To create therapies designed to strengthen hearts affected by congenital heart disease while minimizing the risk of immune rejection.

Read More

Send A Message

This field is for validation purposes and should be left unchanged.
Name(Required)
Please let us know what's on your mind. Have a question for us? Ask away.